COVID-19 Vaccine Response in Chronic Respiratory Conditions
NCT05313087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2026-04-20
Summary
The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boosters) in adults and children including patients with chronic medical conditions.
Conditions
- SARS-CoV Infection
Interventions
- BIOLOGICAL
-
assess response to vaccine
Sponsors & Collaborators
-
National Jewish Health
lead OTHER
Principal Investigators
-
Barry Make, MD · National Jewish Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-03
- Primary Completion
- 2023-12-30
- Completion
- 2023-12-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
NCT02787863 ·Status: COMPLETED ·Phase: PHASE4
-
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NCT05280132 ·Status: RECRUITING ·Phase: NA
-
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942 ·Status: COMPLETED
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD
NCT01516437 ·Status: COMPLETED ·Phase: NA
-
Microbial and Cytokine Signatures in Long COVID Patients
NCT07074158 ·Status: ENROLLING_BY_INVITATION
-
Understanding COVID-19
NCT04329546 ·Status: COMPLETED
-
Infection Watch Study
NCT04623047 ·Status: COMPLETED
-
Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children
NCT04838834 ·Status: COMPLETED
-
Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis
NCT04842708 ·Status: COMPLETED ·Phase: NA
-
Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)
NCT01861184 ·Status: COMPLETED
-
Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly
NCT01360398 ·Status: COMPLETED ·Phase: NA
-
(VIII): The Eight Study and Immunologic Response Sub-study
NCT05237024 ·Status: UNKNOWN
-
A Rapid Test for Acute Respiratory Illness
NCT03192072 ·Status: COMPLETED
-
Surveillance of Healthcare-associated Infections & Antimicrobial Resistance
NCT05734391 ·Status: ENROLLING_BY_INVITATION
-
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886 ·Status: COMPLETED
-
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
NCT05903352 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
NCT05661604 ·Status: COMPLETED
-
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
NCT06597396 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms
NCT04356586 ·Status: COMPLETED
-
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895 ·Status: COMPLETED ·Phase: NA
-
Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study
NCT02557958 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients
NCT05976581 ·Status: COMPLETED ·Phase: NA
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)
NCT04498325 ·Status: WITHDRAWN ·Phase: PHASE1